Five things to know about first-ever FDA-approved pill for postpartum depression
(NEW YORK) -- A new medication just approved by the U.S. Food and Drug Administration could revolutionize the treatment of postpartum depression, a condition that affects as many as 1 in 8 women who have recently given birth.The medication, zuranolone, to be sold under... Read More.
